Analystreport

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. They now have a $181.

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com